Medospir

Spironolactone, the active ingredient in Medospir, is a potassium-sparing diuretic presented as an oral tablet for oral use. It is used to manage hypertension, edema associated with heart failure, primary hyperaldosteronism, and hirsutism in women with polycystic ovary syndrome.

GNH USA supplies Medospir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Spironolactone acts on aldosterone‑mediated pathways to treat several cardiovascular and endocrine conditions. - Hypertension: helps lower blood pressure by reducing sodium retention. - Heart‑failure related edema: promotes fluid loss while conserving potassium. - Primary hyperaldosteronism: counteracts excess aldosterone activity. - Hirsutism in PCOS: reduces androgen‑driven hair growth in affected women.

Spironolactone may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Hyperkalemia: elevated blood potassium levels. - Gynecomastia: breast tissue enlargement, especially in males. - Menstrual irregularities: changes in cycle length or flow.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Acute renal failure in susceptible patients. - Anaphylactic reactions or severe skin rash.

Before initiating therapy, consider the following safety measures. - Renal function monitoring: assess creatinine and electrolyte levels regularly. - Hyperkalemia risk: avoid use with other potassium‑sparing agents. - Pregnancy and lactation: use only if the potential benefit outweighs risk. - Concomitant medications: review for drugs that affect potassium balance. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Spironolactone can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause dangerous hyperkalemia. - Potassium supplements: increase risk of elevated serum potassium. - NSAIDs: can impair renal function and potentiate potassium retention.

Moderate Interactions (Monitor Closely): - Digoxin: higher serum levels may occur. - Lithium: reduced clearance may lead to toxicity. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole): may raise potassium levels.